Trials / Completed
CompletedNCT01505751
The Association of G9a Protein and the Outcome of Patients With Cervical Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 69 (actual)
- Sponsor
- Far Eastern Memorial Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
G9a protein was approved to be highly associated with recurrence of breast cancer, gastric cancer, hepatocellular cancer, prostate cancer and lung cancer. Therefore, the aim of this study was to clarify the association and G9a protein and cervical cancer by analyzing the immunohistochemical staining of G9a protein to the histopathologic specimen of cervical cancer and clinical data.
Conditions
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2012-01-09
- Last updated
- 2016-09-07
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01505751. Inclusion in this directory is not an endorsement.